Tag: pharmaceuticals
-
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience innovator making moves with its groundbreaking sublingual (under-the-tongue) drug delivery technology. This technology, now in the process of securing national-level patents globally, represents a shift from…
-
Alpha Cognition Inc (ACOG.C) has navigated the Alzheimers FDA process like a champ
People really don’t like pharma companies in Canada. We’ve had some monster megacorporations come out of Canada in the pharma space, and the biotech space, and a lot of them turned out to be robber baron villains with twirly moustaches looking to monetize mom’s ailments in ways that ensure the highest possible return in the…
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
![Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets]()
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis…
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
-
![Lucy Loves Luchre: Medexus Pharmaceuticals (MDP.T) is growing fast, keeping the bottom line trim]()
Lucy Loves Luchre: Medexus Pharmaceuticals (MDP.T) is growing fast, keeping the bottom line trim
Hey y’all, Lucy Copperpot back for more analysis of Equity.Guru companies – this one is no longer on the client list, but I asked for permission to dig in anyway because I really think a ton of risk has been removed from Medexus Pharmaceuticals (MDP.T) that the market hasn’t factored in, and that’s a real…
-
![Private med reformulator SecureDose acquired by PharmaDrug Inc (PHRX.C)]()
Private med reformulator SecureDose acquired by PharmaDrug Inc (PHRX.C)
A few weeks back, in what has become a seminal Equity.Guru piece about the quickly legalizing safe supply drug space, I tore into PharmaDrug (PHRX.C), which was lurching into strategic alternatives land as it appeared to have run out of dough to push its drug trials forward. Pharmadrug (PHRX.C) would love to be in the cocaine…
-
![Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting]()
Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the best tradition of Howe Street, long dormant mining companies suddenly became med-tech deals, hawking everything from clear plastic checkout counter dividers to virus sniffing doorways to…
-
![Pubco cocaine is here: What does it mean, who’s in, and who’s real?]()
Pubco cocaine is here: What does it mean, who’s in, and who’s real?
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl in everything?” I’d asked myself the same question many times – why kill your customers? I’d recommend you go listen because the answer is a lot…
-
![The Core Story: Medexus Pharmaceutical (MDP.T) just grows and grows]()
The Core Story: Medexus Pharmaceutical (MDP.T) just grows and grows
Continuing out Core Story program, today’s exploration is a company we just can’t get enough of, Medexus Pharmaceuticals (MDP.T). CEO Ken D’Entremont has nailed his milestones the last 18 months, continued running revenues up, kept expenses low, and restructured convertible debt to remain in control os his company’s direction going forward. They’ve blasted through a…
